HealthTech Innovation Days

Smart Immune

Description

Smart Immune is a clinical-stage biotechnology company developing ProTcell, a thymus- empowered T cell progenitor platform to rapidly re-arm the immune system against cancer and infection. The company aims to radically improve outcomes for patients in hematology and immuno-oncology. SMART101 is in Phase I/II trials for patients with acute leukemia or severe combined immunodeficiencies (SCID), in the EU and the US. Additional clinical applications are planned to be evaluated in combination with innovative cancer therapies.

Company members

On site for the event: Cristina Claver-Sicilia (market access project managerà, Jeremy Gaillard (CFO&CBO), and Karine Rossignol (CEO&Co-founder)